How reliable is the CA125?

23rd July 2021

While the CA125 blood test is useful for diagnosing and monitoring people with ovarian cancer, 25% of ​patients with ovarian cancers will have a normal CA125 level. Therefore, the CA125 test alone is not an accurate diagnostic tool ​and primary care professionals should consider requesting an ultrasound scan if clinical concern persists despite a normal CA125.

To learn more, access GatewayC’s ‘Ovarian Cancer – Early Diagnosis’ course. This course aims to support healthcare professionals to recognise symptoms, understand genetic risk factors and comprehend essential investigations.

Find out more:

  • Access GatewayC’s ‘Ovarian Cancer – Early Diagnosis’ course here
  • Watch GatewayC Live’s webinar recording on Diagnosing Ovarian Cancer here
  • Read Ovarian Cancer Action’s guide for primary care here
  • Read GatewayC’s ‘Tips to elicit your patient’s family history of BRCA1 and BRCA2’ blog here

LinkedIn | Twitter | Facebook

Latest from the Blog

Cancer Keys: MSCC Red Flags

Cancer Keys: MSCC Red Flags

27th May 2020 Potential pitfall: Metastatic spinal cord compression (MSCC) is a medical emergency which can result in paralysis. Many patients living with cancer have pain; within primary care it can difficult to differentiate between significant pain which may be due...

read more

Related Posts

FIT vs gFOBTs: What’s changed? 

FIT vs gFOBTs: What’s changed? 

18th October 2019 The new Faecal Immunochemical Test (FIT) rolled out across England this year has a number of benefits in replacing the use of older guaiac-based faecal occult blood tests (gFOBTs). Is your practice up to date with the new processes associated with...

read more
New tool for GPs to tackle late cancer diagnosis

New tool for GPs to tackle late cancer diagnosis

18 July 2019 New tool for GPs to tackle late cancer diagnosis A new patient-recommended tool for GPs is being launched across England in a bid to catch cancers sooner. Known as GatewayC, the innovative online training tool has already shown promising early signs of...

read more